Description

Mesalamine Prolonged Release Tablets IP 1200 Mg – SALZICA 1200 PR

Composition – Mesalamine Prolonges Release 1200 mg

Description:
SALZICA 1200 PR contains Mesalamine Prolonged Release Tablets IP 1200 mg, an anti-inflammatory agent indicated for the treatment and maintenance of remission in Ulcerative Colitis. Its prolonged-release formulation ensures targeted delivery of Mesalamine throughout the intestinal tract, helping reduce inflammation and maintain mucosal healing for long-term disease control.

Key Points:

• Targeted Colonic Delivery – Prolonged-release technology ensures Mesalamine reaches the colon, providing effective localized anti-inflammatory action.
• Effective Control of Intestinal Inflammation – Helps reduce inflammation, discomfort, and disease activity associated with Ulcerative Colitis.
• Supports Long-Term Remission – Regular therapy helps maintain symptom control and minimizes the risk of disease recurrence.
• Promotes Mucosal Healing – Aids in healing the intestinal lining, supporting better gut function and overall patient outcomes.
• Enhanced Convenience and Compliance – High-strength 1200 mg formulation enables simplified dosing and improved treatment adherence.

Targeted Specialties:
Gastroenterology
General Medicine
Internal Medicine
Colorectal Surgery

Disclaimer:
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.